Pharmacological and molecular insights into β-glucan-rich Saccharomyces cerevisiae var. boulardii: In vivo and in silico protection against arsenic-induced redox and hematologic imbalance
Abstract
Background: Arsenic toxicity remains a major environmental and pharmacological concern in sub-Saharan Africa, with limited safe antidotes. Chronic exposure induces oxidative stress, hematologic dysfunction, and multi-organ injury through redox imbalance. Saccharomyces cerevisiae var. boulardii (SCb), a β-glucan-rich probiotic yeast, possesses antioxidant and immunomodulatory properties that may mitigate arsenic toxicity. This study combined in vivo and in silico approaches to elucid...
More